Back to Journals » Clinical Pharmacology: Advances and Applications » Volume 12

The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Expression of Concern]

Authors Hinz M, Stein A, Cole T

Received 14 April 2020

Accepted for publication 14 April 2020

Published 23 April 2020 Volume 2020:12 Pages 43—44

DOI https://doi.org/10.2147/CPAA.S240231


Hinz M, Stein A, Cole T. Clin Pharmacol Adv Appl. 2014;6:161–169.

The Editor-in-Chief and Publisher of Clinical Pharmacology: Advances and Applications wish to issue an Expression of Concern for the published article.

Concerns have been raised regarding the alleged undisclosed competing interests of some of the authors for the published article. Clinical Pharmacology: Advances and Applications would like to alert readers of this while our investigation is still ongoing and we will provide an update following the conclusion of our investigation.

The authors have been informed of these concerns and of our investigation.


Read the original article

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]